These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 14680428)

  • 1. Commentary: government perspective.
    Parks JJ
    J Clin Psychiatry; 2003; 64 Suppl 17():37-8. PubMed ID: 14680428
    [No Abstract]   [Full Text] [Related]  

  • 2. Missouri Medicaid reform...what can physicians do?
    Halverson LW
    Mo Med; 2006; 103(2):102-5. PubMed ID: 16703704
    [No Abstract]   [Full Text] [Related]  

  • 3. Rx cost control: what's your role?
    Guglielmo WJ
    Med Econ; 2003 Feb; 80(4):27-8, 31-2. PubMed ID: 12666646
    [No Abstract]   [Full Text] [Related]  

  • 4. Examination of the effects of financial risk on the formal treatment costs for a Medicaid population with psychiatric disabilities.
    Jones K; Chen HJ; Jordan N; Boothroyd RA; Ramoni-Perazzi J; Shern DL
    Med Care; 2006 Apr; 44(4):320-7. PubMed ID: 16565632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication restrictions: feeling the side effects.
    Fitzpatrick C
    Behav Healthc Tomorrow; 2001 Oct; 10(5):14-7, 39-40. PubMed ID: 11594068
    [No Abstract]   [Full Text] [Related]  

  • 6. States' control of prescription drug spending: a heterogeneous approach.
    Morden NE; Sullivan SD
    Health Aff (Millwood); 2005; 24(4):1032-8. PubMed ID: 16012143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New York Medicaid: never can say goodbye.
    Fastiggi J
    Cornell J Law Public Policy; 2007; 16(3):581-615. PubMed ID: 18521998
    [No Abstract]   [Full Text] [Related]  

  • 8. Trends in mental health cost growth: an expanded role for management?
    Frank RG; Goldman HH; McGuire TG
    Health Aff (Millwood); 2009; 28(3):649-59. PubMed ID: 19414870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicaid drug programs.
    McGovern J
    Nurs Homes; 1980; 29(1):30-1. PubMed ID: 10297673
    [No Abstract]   [Full Text] [Related]  

  • 10. Using clinical evidence to manage pharmacy benefits: experiences of six states.
    Bergman D; Hoadley J; Kaye N; Crowley J; Hostetter M
    Issue Brief (Commonw Fund); 2006 Mar; (899):1-14. PubMed ID: 16562357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced drug coverage saved Medicaid 'pennies,' cost state 'pounds'.
    Am J Hosp Pharm; 1994 Nov; 51(21):2622. PubMed ID: 7856574
    [No Abstract]   [Full Text] [Related]  

  • 12. Medicaid managed care and the distribution of societal costs for persons with severe mental illness.
    Shern DL; Jones K; Chen HJ; Jordan N; Ramoni-Perazzi J; Boothroyd RA
    Am J Psychiatry; 2008 Feb; 165(2):254-60. PubMed ID: 18198269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Need for therapeutic guidelines for antipsychotics under a prescription cap.
    Sutherland LG
    Am J Health Syst Pharm; 1998 Dec; 55(24 Suppl 4):S19-22. PubMed ID: 9872690
    [No Abstract]   [Full Text] [Related]  

  • 14. Prescription drug benefits under Part D of the Medicare Modernization Act--the genie's out of the bottle.
    Andersen LS
    Issue Brief Cent Medicare Educ; 2005; 5(10):1-10. PubMed ID: 15943013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Commentary: purchasing community perspective.
    Moore MC
    J Clin Psychiatry; 2003; 64 Suppl 17():33-4. PubMed ID: 14680426
    [No Abstract]   [Full Text] [Related]  

  • 16. Restrictive formularies counterbalanced by higher admissions, medical costs.
    Anderson J
    Rep Med Guidel Outcomes Res; 2000 Jan; 11(2):8-10. PubMed ID: 11768404
    [No Abstract]   [Full Text] [Related]  

  • 17. The ripple effects of a restrictive Medicaid formulary.
    Grabowski H
    Am J Manag Care; 2003 Oct; 9(10):648-9. PubMed ID: 14572174
    [No Abstract]   [Full Text] [Related]  

  • 18. Commentary: health care organization perspective.
    Goldman W
    J Clin Psychiatry; 2003; 64 Suppl 17():35-6. PubMed ID: 14680427
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes in Medicaid prescription volume and use in the wake of Medicare Part D implementation.
    Bruen BK; Miller LM
    Health Aff (Millwood); 2008; 27(1):196-202. PubMed ID: 18180495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease management and mental health.
    Regan J; Outlaw F; Hamer G; Wright A; White C
    Tenn Med; 2004 Aug; 97(8):363-5. PubMed ID: 15376712
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.